HSR-609
Code | Size | Price |
---|
TAR-T27556-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T27556-50mg | 50mg | £1,661.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T27556-100mg | 100mg | £2,079.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
HSR-609, a histamine H1 receptor antagonist, is used potentially for the treatment of allergic rhinitis.
CAS:
161522-25-4
Formula:
C21H21FN2O3
Molecular Weight:
368.408
Purity:
0.98
SMILES:
OC(=O)CCN1CCC(CC1)=C1c2ccc(F)cc2OCc2cccnc12
References
1. Salmun LM. Antihistamines in late-phase clinical development for allergic disease. Expert Opin Investig Drugs. 2002 Feb;11(2):259-73. Review. PubMed PMID: 11829715.
2. Musoh K, Nakamura N, Nagai H. Effects of an amphoteric antiallergic agent, HSR-609, on antigen-induced late phase nasal eosinophilia in brown Norway rats. Pharmacology. 2000 Nov;61(4):230-7. PubMed PMID: 11093074.
3. Musoh K, Maeda Y, Tanaka H, Inagaki N, Nagai H. Effect of a novel anti-allergic agent, HSR-609, on antigen-induced airway hyperresponsiveness in mice. Pharmacology. 2000 Aug;61(2):70-7. PubMed PMID: 10940779.
4. Kakiuchi M, Ohashi T, Tanaka K, Ohara N, Kamiyama K, Morikawa K, Kato H. Central nervous system effects of the novel antiallergic agent HSR-609 and typical antiallergic agents using behavioral and electroencephalographic analyses in dogs. Nihon Shinkei Seishin Yakurigaku Zasshi. 1998 Oct;18(5):189-99. PubMed PMID: 10028490.